Kaposi Sarcoma (KS)–Associated Herpesvirus MicroRNA Sequence Analysis and KS Risk in a European AIDS‐KS Case Control Study | Zendy

Vickie Marshall | Zendy; Elisa Martró | Zendy; Nazzarena Labò | Zendy; Alex Ray | Zendy; Dian Wang | Zendy; Georginia Mbisa | Zendy; Rachel Bagni | Zendy; Natalia Volfovsky | Zendy; Jordi Casabona | Zendy; Denise Whitby | Zendy

Open Access

Kaposi Sarcoma (KS)–Associated Herpesvirus MicroRNA Sequence Analysis and KS Risk in a European AIDS‐KS Case Control Study

Author(s) -

Vickie Marshall,

Elisa Martró,

Nazzarena Labò,

Alex Ray,

Dian Wang,

Georginia Mbisa,

Rachel Bagni,

Natalia Volfovsky,

Jordi Casabona,

Denise Whitby

Publication year - 2010

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/656045

Subject(s) - biology , kaposi's sarcoma associated herpesvirus , microrna , viral load , polymerase chain reaction , virology , gene , virus , peripheral blood mononuclear cell , gammaherpesvirinae , real time polymerase chain reaction , case control study , sarcoma , immunology , herpesviridae , kaposi's sarcoma , viral disease , genetics , human herpesvirus , pathology , medicine , in vitro

We recently identified polymorphisms in Kaposi sarcoma-associated herpesvirus (KSHV)-encoded microRNA (miRNA) sequences from clinical subjects. Here, we examine whether any of these may contribute to KS risk in a European AIDS-KS case-control study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research